Transcripts
Aquestive Therapeutics (AQST) earnings call transcripts
Earnings call transcripts for Aquestive Therapeutics, Inc., with a summary, the guidance given, and what analysts pressed on.
- Q2 2026 earnings call
Management framed Anaphylm’s resubmission as substantially de-risked, while emphasizing focused launch preparation and expanding dermatology optionality.
Aug 12, 2026Confident0.84